ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team

on

ClearNote Health announced four new executive appointments:
Jeffrey Venstrom, MD as Chief Medical Officer; Daniel Black, DBA as General Manager of International Markets; Irene Hsieh as Vice President of Regulatory Affairs and Quality Assurance; Jeremy Bennett as Head of Marketing.1

These hires aim to expand clinical validation, advance regulatory pathways, and drive global adoption of early cancer detection tests.1

Dr. Venstrom previously served as global head of diagnostics at Eli Lilly, CMO at Grail, and held roles at Roche/Genentech and UCSF.1

The company recently enhanced its Avantect® Pancreatic Cancer Test, a blood-based test for high-risk patients using multianalyte, multiomic approach with machine learning.1

Announcement made on March 18, 2026, via Business Wire.1

Sources:

1. https://www.businesswire.com/news/home/20260318166082/en/ClearNote-Health-Appoints-Jeffrey-Venstrom-MD-as-Chief-Medical-Officer-and-Expands-Leadership-Team-to-Drive-Clinical-Adoption-of-Early-Cancer-Detection-Tests